What is VTVT's health score?

vTv Therapeutics Inc. (VTVT) has a TradeApes health score of 44 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is VTVT's estimated fair value?

Based on our 5-year discounted cash flow model, vTv Therapeutics Inc.'s estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is VTVT undervalued or overvalued?

Our model currently rates VTVT as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for VTVT... Refresh in a moment for the full analysis.

vTv Therapeutics Inc. (VTVT)

Healthcare Inconclusive inconclusive weak

$34.35

Updated: 2026-06-05

TradeApes Score

Financial Strength

5 Stressed

Operating Trend

65 Healthy

Relative Value

50 Mixed

Capital Allocation

40 Weak

Risk

80 Strong

Key Findings

+ Strong revenue growth — sales up more than 20% year over year

Unlock Full Report →

− Very high leverage — net debt/EBITDA above 5×

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.